Microbot Medical Inc
MBOT2.580USD
+0.030+1.18%
시장 운영 시간 （ET）시세는 15분 지연됩니다
89.64M시가총액
손실P/E TTM
자세한 내용은 Microbot Medical Inc 회사
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
회사 정보
종목 코드 MBOT
회사 이름Microbot Medical Inc
상장일Mar 25, 1992
CEOMr. Harel Gadot
직원 수21
유형Ordinary Share
회계 연도 종료Mar 25
주소175 Derby St Bld 27
도시HINGHAM
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호02043
전화17818753605
웹사이트http://www.microbotmedical.com/
종목 코드 MBOT
상장일Mar 25, 1992
CEOMr. Harel Gadot
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
주주
주주
비율
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
주주 유형
주주
비율
Investment Advisor
6.96%
Investment Advisor/Hedge Fund
1.74%
Research Firm
0.36%
Venture Capital
0.36%
Hedge Fund
0.26%
Other
90.31%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
93
3.70M
9.69%
-538.67K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
2023Q1
63
2.51M
30.86%
-204.69K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
741.16K
2.04%
+281.62K
+61.28%
Mar 31, 2025
Geode Capital Management, L.L.C.
316.92K
0.87%
+174.26K
+122.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
236.10K
0.65%
+98.73K
+71.87%
Mar 31, 2025
MEDX Ventures Group LLC
136.85K
0.38%
--
--
Apr 15, 2025
State Street Global Advisors (US)
136.67K
0.38%
+110.60K
+424.24%
Mar 31, 2025
DNB Asset Management AS
114.82K
0.32%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
104.18K
0.29%
+74.45K
+250.44%
Mar 31, 2025
Two Sigma Investments, LP
83.02K
0.23%
+72.29K
+673.87%
Mar 31, 2025
Northern Trust Investments, Inc.
71.06K
0.2%
+57.67K
+430.78%
Mar 31, 2025
UBS Financial Services, Inc.
41.13K
0.11%
+40.06K
+3765.23%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
비율0.02%
Dimensional US Core Equity 1 ETF
비율0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
